Pancreatic neuroendocrine tumors and pathogenic variants: a multinational study
Background: Germline pathogenic variants (GPV) in MUTYH are rare in patients with pancreatic neuroendocrine tumors (PanNET). Objectives: We aimed to characterize PanNET patients with GPV and/or somatic pathogenic variants (SPV) in MUTYH . Design: Retrospective multicenter cohort. Methods: Patients w...
Saved in:
| Main Authors: | Rachel P. Riechelmann, Giovana T. Torrezan, Emily Bergsland, Nitya Raj, Jonathan Strosberg, Farhana Moon, Tiago C. Felismino, Stian Knappskog, Elena Trevizani, Sara Cingarlini, Halfdan Sorbye |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-07-01
|
| Series: | Therapeutic Advances in Medical Oncology |
| Online Access: | https://doi.org/10.1177/17588359251356335 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Germline variants in CDKN2A wild‐type melanoma prone families
by: Gjertrud T. Iversen, et al.
Published: (2025-05-01) -
Peptide receptor radionuclide therapy in G3 gastroenteropancreatic neuroendocrine tumors: a missed opportunity for European patients?
by: Francesco Panzuto, et al.
Published: (2025-08-01) -
A rare case of pancreatic neuroendocrine tumor
by: Raja Rao Nudurupati, et al.
Published: (2020-01-01) -
Emerging innovations in theranostics for pancreatic neuroendocrine tumors
by: Anita Karimi, et al.
Published: (2025-05-01) -
Characterization of the Pancreatic Neuroendocrine Neoplasm Immune Microenvironment
by: Filipe Reis Neves, et al.
Published: (2025-04-01)